Correction to: Conversion of quinazoline modulators from inhibitors to activators of β-glucocerebrosidase (Journal of Medical Chemistry (2019) 62: 3 (1218-1230) DOI: 10.1021/acs.jmedchem.8b01294)

Jianbin Zheng, Sohee Jeon, Weilan Jiang, Lena F. Burbulla, Daniel Ysselstein, Kristine Oevel, Dimitri Krainc, Richard B. Silverman

Research output: Contribution to journalComment/debatepeer-review

Abstract

Page 1228. In the right column, line 22 from the top, "400 μM" should be "400 nM".

Original languageEnglish (US)
Pages (from-to)2850
Number of pages1
JournalJournal of Medicinal Chemistry
Volume62
Issue number5
DOIs
StatePublished - Mar 14 2019

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Correction to: Conversion of quinazoline modulators from inhibitors to activators of β-glucocerebrosidase (Journal of Medical Chemistry (2019) 62: 3 (1218-1230) DOI: 10.1021/acs.jmedchem.8b01294)'. Together they form a unique fingerprint.

Cite this